Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases.
Raja IdrisAnn-Sophie ZielbauerJulia KoepsellJan Andreas KlokaNils WetzsteinPublished in: BMC pulmonary medicine (2024)
ECMO therapy in TB patients appears to be a feasible therapeutic option, providing a bridge until antimycobacterial therapy takes effect. As the underlying cause is reversible, we advocate for the evaluation of ECMO usage in these patients with acute cardiac or respiratory failure.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- end stage renal disease
- mycobacterium tuberculosis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- emergency department
- left ventricular
- heart failure
- hiv aids
- intensive care unit
- atrial fibrillation
- mesenchymal stem cells